|
1
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:15065. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou LL, Zou MD and Li WM: Recent advances
in colorectal cancer-specific nucleic acid aptamers for diagnostic
and therapeutic applications. Sci Adv Mater. 12:38–43. 2020.
View Article : Google Scholar
|
|
4
|
The Lancet Oncology: Colorectal cancer: A
disease of the young? Lancet Oncol. 18:4132017. View Article : Google Scholar
|
|
5
|
Kasi PM, Shahjehan F, Cochuyt JJ, Li Z,
Colibaseanu DT and Merchea A: Rising proportion of young
individuals with rectal and colon cancer. Clin Colorectal Cancer.
18:e87–e95. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K,
Liu X, Xu T, Sun L, Qin J, et al: LncRNA SATB2-AS1 inhibits tumor
metastasis and affects the tumor immune cell microenvironment in
colorectal cancer by regulating SATB2. Mol Cancer. 18:1352019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rathinasamy B and Velmurugan BK: Role of
lncRNAs in the cancer development and progression and their
regulation by various phytochemicals. Biomed Pharmacother.
102:242–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takata M, Pachera E, Frank-Bertoncelj M,
Kozlova A, Jüngel A, Whitfield ML, Assassi S, Calcagni M, de
Vries-Bouwstra J, Huizinga TW, et al: OTUD6B-AS1 might be a novel
regulator of apoptosis in systemic sclerosis. Front Immunol.
10:11002019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Xia F, Feng T, Jiang B, Wang W and
Li X: OTUD6B-AS1 inhibits viability, migration, and invasion of
thyroid carcinoma by targeting miR-183-5p and miR-21. Front
Endocrinol (Lausanne). 11:1362020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang G, Zhang ZJ, Jian WG, Liu PH, Xue W,
Wang TD, Meng YY, Yuan C, Li HM, Yu YP, et al: Novel long noncoding
RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell
renal cell carcinoma proliferation via the Wnt/β-catenin signaling
pathway. Mol Cancer. 18:152019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mahesh G and Biswas R: MicroRNA-155: A
master regulator of inflammation. J Interferon Cytokine Res.
39:321–330. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Yang L, Yu M and Wang J:
Identification and expression analysis of microRNAs during ovule
development in rice (Oryza sativa) by deep sequencing. Plant Cell
Rep. 36:1815–1827. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rane S, Sayed D and Abdellatif M: MicroRNA
with a MacroFunction. Cell Cycle. 6:1850–1855. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei Y, He R, Wu Y, Gan B, Wu P, Qiu X, Lan
A, Chen G, Wang Q, Lin X, et al: Comprehensive investigation of
aberrant microRNA profiling in bladder cancer tissues. Tumour Biol.
37:12555–12569. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Zhao Y, Wang Y and Jin C: Circular
RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by
regulating miR-3171/PTEN axis. Biomed Pharmacother. 116:1089322019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo S, Zhu KX, Yu WH, Wang T, Li S, Wang
YX, Zhang CC, Guo JQ, et al: SH3PXD2A-AS1/miR-330-5p/UBA2
ceRNAnetwork mediates the progression of colorectal cancer through
regulating the activity of the Wnt/beta-catenin signaling pathway.
Environ Toxicol. Oct 19–2020.(Epub ahead of print). doi:
10.1002/tox.23038. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hua RX, Zhuo ZJ, Zhu J, Zhang SD, Xue WQ,
Zhang JB, Xu HM, Li XZ, Zhang PF, He J, et al: XPG Gene
Polymorphisms contribute to colorectal cancer susceptibility: A
two-stage case-control study. J Cancer. 7:1731–1739. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He D, Ma L, Feng R, Zhang L, Jiang Y,
Zhang Y and Liu G: Analyzing large-scale samples highlights
significant association between rs10411210 polymorphism and
colorectal cancer. Biomed Pharmacother. 74:164–168. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Allen C, Barregard L, Bhutta ZA,
Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, Dandona L,
Fleming T, et al: Global, regional, and national cancer incidence,
mortality, years of life lost, years lived with disability, and
disability-adjusted life-years for 32 cancer groups, 1990 to 2015:
A Systematic Analysis for the Global Burden of Disease Study. JAMA
Oncol. 3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X,
Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes
colorectal carcinogenesis and glucose metabolism by stabilizing
c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heo JB, Lee YS and Sung S: Epigenetic
regulation by long noncoding RNAs in plants. Chromosome Res.
21:685–693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Chen Z, Wang X, Huang Z, He Z and
Chen Y: Long non-coding RNA: A new player in cancer. J Hematol
Oncol. 6:372013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q,
Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA
CCAL regulates colorectal cancer progression by activating
Wnt/β-catenin signalling pathway via suppression of activator
protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai B, Song XQ, Cai JP and Zhang S:
HOTAIR: A cancer-related long non-coding RNA. Neoplasma.
61:379–391. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Galamb O, Barták BK, Kalmár A, Nagy ZB,
Szigeti KA, Tulassay Z, Igaz P and Molnár B: Diagnostic and
prognostic potential of tissue and circulating long non-coding RNAs
in colorectal tumors. World J Gastroenterol. 25:5026–5048. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang AH, Fan WJ, Fu L and Wang XT: LncRNA
PCAT-1 regulated cell proliferation, invasion, migration and
apoptosis in colorectal cancer through targeting miR-149-5p. Eur
Rev Med Pharmacol Sci. 23:8310–8320. 2019.PubMed/NCBI
|
|
33
|
Zhang H, Song Y, Yang C and Wu X:
Overexpression of lncRNA TUSC7 reduces cell migration and invasion
in colorectal cancer. Oncol Rep. 41:3386–3392. 2019.PubMed/NCBI
|
|
34
|
Lin J, Chuang CC and Zuo L: Potential
roles of microRNAs and ROS in colorectal cancer: Diagnostic
biomarkers and therapeutic targets. Oncotarget. 8:17328–17346.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Z, Wang Y, Borlak J and Tong W:
Mechanistically linked serum miRNAs distinguish between drug
induced and fatty liver disease of different grades. Sci Rep.
6:237092016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gmerek L, Martyniak K, Horbacka K,
Krokowicz P, Scierski W, Golusinski P, Golusinski W, Schneider A
and Masternak MM: MicroRNA regulation in colorectal cancer tissue
and serum. PLoS One. 14:e02220132019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nagy ZB, Barták BK, Kalmár A, Galamb O,
Wichmann B, Dank M, Igaz P, Tulassay Z and Molnár B: Comparison of
circulating miRNAs expression alterations in matched tissue and
plasma samples during colorectal cancer progression. Pathol Oncol
Res. 25:97–105. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Valeri N, Braconi C, Gasparini P, Murgia
C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat
F, et al: MicroRNA-135b promotes cancer progression by acting as a
downstream effector of oncogenic pathways in colon cancer. Cancer
Cell. 25:469–483. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J,
Zhang CY, Chen J and Zhang J: MicroRNA-31 activates the RAS pathway
and functions as an oncogenic MicroRNA in human colorectal cancer
by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol
Chem. 288:9508–9518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X,
Yu J, Guan X, Jiang BH and Liu LZ: Downregulation of miR-145
associated with cancer progression and VEGF transcriptional
activation by targeting N-RAS and IRS1. Biochim Biophys Acta.
1829:239–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
